Issue 10/2008
Content (191 Articles)
An Automated Standardized System for Managing Adverse Events in Clinical Research Networks
Rachel L. Richesson, Jamie F. Malloy, Kathleen Paulus, David Cuthbertson, Jeffrey P. Krischer
Comparative Risk for Harms of Second Generation Antidepressants
Gerald Gartlehner, Patricia Thieda, Richard A. Hansen, Bradley N. Gaynes, Angela DeVeaugh-Geiss, Erin E. Krebs, Kathleen N. Lohr
Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique
Esperança Sevene, Alda Mariano, Ushma Mehta, Maria Machai, Alexander Dodoo, David Vilardell, Sam Patel, Karen Barnes, Xavier Carné
Drug-Related Nephrotoxic and Ototoxic Reactions
Bertha Maria Verdel, Eugène P. van Puijenbroek, Patrick C. Souverein, Hubert G. M. Leufkens, Antoine C. G. Egberts
Data Mining in Pharmacovigilance Practice: Which Algorithm to Use?
X. Yang, J. Freeman, R. Bwire
Post-Authorization Safety Surveillance of a New Pentavalent Vaccine within a National Childhood Vaccination Program in Central America
K. Hartmann, E. Asturias, U. Aeberhard, C. Spyr
Searching for Drug-Related Adverse Events in PubMed/MEDLINE Using the MeSH Term “Drug Toxicity”
M. O. Garcia, F. A. Guzman
Participation Hospital’s Pharmacist in the Voluntary Reporting Adverse Drug Reactions and Costs Involved in their Management
M. Kyonen, C. Caro, L. Folatre, L. Villa, D. Sosa, L. Acuña, C. Schramm, G. Muñoz
Medicinal Product Safety on the UK Market — A Ten Year study
A. Tang, D. Layton, S. Shakir, D. Brown
Sex-Based Comparative Prevalence Study of Drug-Prescribing Factors Increasing the Antipsychotic-Associated Risk of QT-Prolongation/ Torsade-de-Pointe in the Inpatients of a Psychiatric Hospital
F. Westphal, H. Javelot, C. Nonnenmacher
Do Consumer Reports of Adverse Drug Reactions Add Value or Noise to Postmarketing safety surveillance?
S. Ahmad, L. Westin, L. Aagaard, G. Moses
International Assessment of Herbal Medicines Pharmacovigilance
S. Skaiii, A. Khattabi, R. Souiaymani Bencheikh
A Survey of the Conduct and Reporting of Systematic Reviews Assessing Adverse Effects of Drug Interventions
V. Cornelius, M. Perrio, L. Smith, S. Shakir
Allergic Reactions to Oral Drugs: A Case/Non Case Study from an Italian Spontaneous Reports Database (GIF)
F. Salvo, G. Polimeni, P. M. Cutroneo, R. Leone, A. Conforti, U. Moretti, D. Motola, M. Tuccori, A. P. Caputi
Creating Pharmacovigilance Quality Assurance
T. Cochran, S. Curti, J. Green, H. Motamen, U. Prabhakar
Nimotuzumab Cuban Safety Postmarketing Surveillance
P. Piedra Sierra, G. Saurez Martinez, A. Bencomo Yánez, Y. Pomares Iturralde, Md. C. Barroso Alvarez, N. Iznaga Escobar
Safety Profile of Modafinil Used in General Practice in England: A Modified Prescription Event Monitoring study
M. Davies, L. Wilton, S. Shakir
Psychoactive Herbs Commercialized in Diadema Streets: Ethnopharmacological Data of an Interdisciplinary Study, Brazil
J. Assunção Rodrigues Soares Neto, E. Rodrigues
Novel Approach for Intensive Pharmacovigilance Studies: Application to Hepatitis C Treatment in Mexican Patients
R. Jimenez-Mendez, B. Vergara, G. Castaneda-Hernandez
Psychotropic Drug Used for Attention-Deficit/Hyperactivity Disorder (ADHD) in Italian Children and Adolescent Population
P. Panei, A. L. Kneiiwoif, M. Bonati, G. Masi, A. Zuddas, A. Costantino, R. Arcieri, E. Costabiie
Profile of Drugs Related to Adverse Event at Brazilian University Hospitals
A. M. M. Reis, T. C. Marques, S. P. Opitz, A. E. Bd. C. Silva, S. H. D. R. Cassiani
Potential Drug-Drug Interactions: An Anti-Microbial Study Using Patients Who Undergo Bone Marrow Transplant
S. R. Secoii, R. F. Guastaidi, A. M. M. Reis
Extrapyramidal Side Effects Induced by Trimetazidine
K. Masmoudi, S. Amesiant, C. Chourbagi, V. Gras-Champel, H. Masson, M. Andréjak
Early Post-Marketing Pharmacovigilance of BLASTOFERON®: An Interferon Beta 1a Biosimilar
M. Kauffman, M. Papouchado, E. Gonzalez, A. Sterin-Prync, A. Vidal, R. Diez, H. Ferro
Safety Profile of Extended Release Formulation of Nimesulide in Asian Indian Population: A Prescription Event Monitoring Programme
M. Sharma, A. Chatterjee, S. K. Gupta, V. B. Gupta
The Use of Lumiracoxib in General Practice in England: Results of a Modified Prescription-Event Monitoring study
D. Layton, V. Marshall, S. Shaklr
Pharmacovigilance Characteristics and Activities within the First Cohort of EU Risk Management Plans (RMPs): Small Molecules vs. Biologicals
T. J. Giezen, A. K. Mantel-Teeuwisse, S. M. J. M. Straus, A. C. G. Egberts, I. Persson, H. G. M. Leufkens
Neurological Adverse Side-Effects Induced by Cloxacillin
C. Maugard, F. Marçon, L. Hary, H. Masson, M. Andréjak, A. Lemaire-Hurtel
Cutaneous and Corneal Ulcerations Under Nicorandil: A Case Report
M. Ollagnier, C. Guy, P. Gain
Medication Errors Management in Hospital: Three-Month Results
L. Thomas, C. Cordonnier-Jourdin, C. Diviné, G. Benhamou-Jantelet, B. Lucet, H. Le Louet
Dermaological Adverse Reactions Associated to Lamotrigine
P. Mariani, C. Santucci, B. Cardoso, I. Bignone
The Pharmacovigilance of Vaccines in the National Center of Mexico
B. Vergara, Md. C. Becerril
Reports of Serious Adverse Drug Reactions
M. R. Gruszycki, D. A. Alba, A. E. Gruszycki, A. L. Tauguinas, R. M. Osicka
A Systematic Literature Review of the Determinants of Signal Detection In Post-Marketing Surveillance Systems
G. L. Ferreira, S. S. Shakir, D. Brown
Improving Spontaneous Reporting of Adverse Drug Reactions: A Trial among Pharmacists
I. Vaz, M. T. Herdeiro, J. Polonia, A. Figueiras
From Spontaneous Adverse Drug Reporting to Legislation Change of Ketorolac in Taiwan
W. Chen, C. Gau, Y. Hsieh
Continuity of Treatment and Data Transmission: A High-Risk Time for Adverse Effects due to Drugs, Especially for Oral Anticoagulant Therapy
S. Amesiant, C. Chourbagi, V. Brenet-Dufour, H. Masson, M. Andréjak, J. Moragny, V. Gras-Champei
Hypoglycaemia with Pioglitazone: Analysis of data from the Prescription-Event Monitoring (PEM) Study
V. Vlckova, V. Cornelius, R. Kasliwal, Y. Buggy, L. Wilfon, S. Shakir
Association of Cardiovascular Drugs and NOS1AP with QTc Prolongation
C. van Noord, A. Aarnoudse, M. Sturkenboom, S. Straus, J. Witteman, B. Stricker
Analysis of Venous Thromboembolism in the Strontium Ranelate Prescription-Event Monitoring (PEM) Cohort: Interim Results
M. Perrio, L. Wilton, S. Shakir
From an Identified Risk to Regulatory Measures: Implementation of HLA-B★5701 Screening Before Abacavir Treatment
N. Cachin, C. Kreft-Jais
Therapeutic Drug Monitoring of Antidementia Drugs: A Valid Tool for Successful Individual Benefit/Risk Evaluation
R. Koeber, H. H. Kluenemann, D. Melchner, E. Haen
The Monitoring of Serum Electrolytes and Creatinine in Patients Treated with Antihypertensive Drugs: A Retrospective Analysis in UK General Practice
J. J. Coleman, S. E. McDowell, R. E. Ferner
Medicines: To Drive or Not to Drive.. Epilogue
A. Bénard-Laribière, E. Fort, T. Floresta, N. Fone-Tchoura, A. Pasturaud, G. Miremont-Salamé, N. Moore, C. Séries, F. Haramburu
Data Mining on Large Health Record Databases for Detecting Adverse Reactions: Which Events to Monitor?
G. Trifiro’, A. Pariente, G. Polimeni, G. Miremont-Salame’, M. A. Catania, F. Salvo, A. David, N. Moore, A. P. Caputi, M. Sturkenboom, J. van der Lei, A. Fourrier-Reglat
The Beginning of Pharmacovigilance in a Public Industry
J. P. Carvalho, A. C. Abritta, A. V. Luna
Case 02-2007 “A 62 Year Old Patient with Hypertension Crisis, Tachycardia and Severe Headache”
P. Lipszyc, M. V. Cerisola, S. J. Setton, C. Pagnini, F. Lipszyc
Analysis of Drug Adverse Reaction Relief Applications in Taiwan from 1999–2007
L. Kuo-Hua, Y. Hsiu-Chiung, G. Churn-Shiouh, L. Min-Shung
Where Does the Evidence for Guidelines Come From? An Example of Monitoring for the Adverse Renal Effects of ACE Inhibitors
J. J. Coleman, S. E. McDowell, R. E. Ferner
An Observational Study of Adverse Drug Reactions in Patients of a New Zealand General Hospital: Incidence of Hyperuricaemia
C. Anton, B. S. Hebron, H. J. Hebron
Non-Drug Related Adverse Complaints in Volunteers to Phase I Studies and in Normal Population
L. Almeida, H. Gama, T. Nunes, R. Coelho, M. Vaz-da-Silva, A. Albino-Teixeira, P. Soares-da-Silva
Comparison of Adverse Reactions Notified with Three Step 2 Analgesic Associations in France: Dextropropoxyphen + Acetaminophen, Tramadol + Acetaminophen, Codeine + Acetaminophen
N. Tavassoli, G. Durrieu, J. L. Montastruc
Paresthesia with Spiramycin Treatment
H. Théophile, B. Julliac, G. Miremont-Salamé, F. Haramburu
Genotyping in the TDM Laboratory — Necessary for Pharmacovigilance?
A. Hader, D. Melchner, J. Kirchheiner, E. Haen
Episodes of Amnesia and Other Neuropsychiatric Disturbances During the Use of Zolpidem and Other Non-Benzodiazepine Hypnotics
R. Meyboom, M. Doraiswamy, A. Viklund
Reports of Seizures Caused by Drugs
M. R. Gruszycki, D. A. Alba, A. E. Gruszycki, A. L. Tauguinas, R. M. Osicka
Adverse Drug Reactions and Off-Label Drug Use in Paediatric Patients: A One-Year Survey of the French Pharmacovigilance Database
G. Durrieu, V. Raoul, J. Montastruc
Potential Drug-Drug Interactions in a Cohort of Patients Who Underwent Radiodiagnostic Procedures: An In-Hospital Survey
F. Lapi, M. Moschini, M. Vietri, E. Cecchi, G. Banchelli, M. Di Pirro, E. Gallo, A. Fazzini, A. Vannacci
Risk Minimisation Activities to Minimise Drug-Related Risks: An Overview of Current Practice
T. J. Giezen, F. Moral, A. K. Mantel-Teeuwisse, M. van Dartel, S. M. J. M. Straus, S. H. Mülder, B. J. van Zwieten-Boot
Master in Pharmacovigilance: A Training Programme to Improve the Quality of a Drug Surveillance System
M. Di Pirro, M. Moschini, F. Lapi, M. Vietri, E. Cecchi, G. Banchelli, E. Gallo, A. Fazzini, A. Mugelli, A. Vannacci
Memory loss and Confusion with Statins — An Analysis of Spontaneous Case Reports Using the DoTs Classification Scheme
C. Anton, A. R. Cox, R. E. Ferner
Patients Starting Anti-Obesity Drugs Carry Higher Psychiatric and Cardiovascular Baseline Risk
M. J. Willemen, A. K. Mantel-Teeuwisse, S. M. Straus, A. C. Egberts, H. G. Leufkens, M. C. Sturkenboom
Adverse Drug Reactions with Donepezil: Analysis of the French Pharmacovigilance Database
S. Babai, W. E. Bourzam, H. Brocvielle, H. Le Louët
Psychiatric Disorders with Anti-TNFalpha Treatment: An Adverse Drug Reaction to Keep in Mind
H. Théophile, B. Debray, G. Miremont-Salamé, E. Shipley, T. Schaeverbeke, F. Haramburu
Recurrent Upper Gastrointestinal Bleeding Associated with Acenocoumarol and Enoxaparin
G. A. Keller, A. Yufra, G. Avila, G. Di Girolamo
Worldwide Pharmacovigilance of a Biosimilar Product Containing Epoetin (Hemax®)
H. Ferro, H. Donato, R. Valtuille, E. Gonzalez
Acute Hypersensitivity Reactions to Andrographis paniculata Containing Products, as Reported in International Pharmacovigilance
M. Farah, R. Meyboom, M. Ploën
HMG CoA Reductase Inhibitors and impotence: Results of a Case/Noncase study in the French PharmacoVigilance Database
C. Do, E. Huyghe, G. Durrieu, J. Montastruc, H. Bagheri
Evidences of Efficacy and Safety of Over-the-Counter Medications for Cough Registered in Brazil: A Challenge to Pharmacovigilance
A. M. M. Reis, A. Figueras
Analysis of Pediatric Use Information on Package Insert of Antimicrobial Drugs
A. C. S. Gonçalves, C. M. Caixeta, A. M. M. Reis
Cefepime Neurotoxicity Identified by Intensified Surveillance at Brazilian University Hospital
M. C. P. Souza, Md. D. G. Silva, M. M. Godin, P. V. Gandini, A. M. M. Reis
Pharmacovigilance within the Internal Medicine Division of Argerich Hospital
M. Ponte, G. Di Girolamo, G. Keller, N. Terragno
Voriconazole-Induced Leaky Capillary Syndrome (Case Report)
M. Ponte, Di G. Girolamo, G. Keller, N. Terragno
Evidence to Support the Regulation Decision for the Usage of Pergolide in Patients with Parkinson’s Disease in Taiwan
C. Gau, P. Lii, C. Hsu
Evaluating Prescriber Characteristics Associated with NSAID Prescribing Practices in the Netherlands
D. Layton, P. Souverein, E. Heerdink, T. Egberts, S. Shakir
Ventricular Arrhythmia and Sudden Unexpected Death and Domperidone
C. van Noord, J. Dieleman, K. Verhamme, M. Sturkenboom
Assessment of Blood Products Demand in the Treatment of Adverse Drug Reactions in German Hospitals
M. Rottenkolber, S. Schmiedl, D. Rottenkolber, J. Hasford
Pharmacovigilance from the University: Experience in the Report of Adverse Events and Lack of Efficiency
P. S. Lipszyc, S. J. Setton, M. V. Cerisola, J. E. Vales, D. Scublinsky
Pharmacovigilance and Patient Safety — Results of the German Net of Regional Pharmacovigilance Centers
J. Hasford, M. Rottenkolber, J. Szymanski, S. Mueller, G. Haase, K. May, I. R. Guenther, M. Hippius, P. A. Thuermann
Hospital Admissions due to Adverse Drug Reactions: EMIR, a Nationwide Study
G. Miremont-Salamé, A. Bénard-Laribière, M. Perault Pochat, J. Imbs, F. Haramburu
A Tool for Preventing Medication Errors Due to Similar Labeling and Packaging of Drugs in a Brazilian Teaching Hospital
M. C. Sakai, P. Luppi Jr, P. S. K. Takahashi, A. B. Sousa, E. Ribeiro
Non-Drug Adverse Symptoms are Influenced by the Personality Trait Anxiety
L. Almeida, H. Gama, M. Vaz-da-Silva, T. Nunes, R. Coelho, A. Albino-Teixeira, P. Soares-da-Silva
Subjects High in Anxiety and Low in Perceived Self-Efficacy Tend to Report More Adverse Events in Phase I studies
L. Almeida, H. Gama, M. Vaz-da-Silva, T. Nunes, R. Coelho, A. Albino-Teixeira, P. Soares-da-Silva
Infovigilance: Notification of Errors from Official Drug Information sources
M. C. Husson, L. Fusier, C. Jollier, M. Ollagnier
Policy for the Management of the Pharmacovigilance Unified system in the Province Of Cordoba (SUFV)
K. Gatica, M. Rencoret, P. Martinez, C. Montachini, A. Segura, A. Welter, J. Losano, E. Ríos, A. Ramirez de Maffrand, L. Alesso, M. Caffaratti, M. E. Olivera, C. Roitter, V. Tauro, A. Cuella, E. Virzi, G. Ascar, G. Falabella, F. Mera, M. L. Maggi, V. Alvarez, E. Quinzio, A. Aguzzi, G. Aramburu
Potential Drug-Drug Interactions in Patients with coronary Artery Disease
S. R. Secoli, N. Danzi, G. Lorenzi-Filho, L. César, F. Nunes, A. Amaro, L. Drager, A. M. M. Reis
Evaluation of the Reports Related to Drug Quality Problems from January 2001 to December 2007 in a Brazilian Teaching Hospital
M. C. Sakai, P. S. K. Takahashi, D. Barbosa, A. B. Sousa, E. Ribeiro
Finasteride-Associated Central Serious Chorioretinopathy
R. Lombardo, A. Loraschi, S. Lecchini, M. Cosentino
Collaborative Hospital-Based Surveillance Network of Drug-Induced Pancreatitis: A Feasibility Study in Italy
A. Loraschi, A. Volontè, C. Klersy, C. M. Castelletti, L. Tosi, S. Lecchini, M. Cosentino
Intensive Monitoring of Adverse Drug Reactions in HIV Patients: A Hospital-Based Study in Italy
A. Loraschi, A. Volonte, C. Klersy, C. M. Castelletti, L. Tosi, T. Quirino, S. Lecchini, M. Cosentino
Pseudolymphomatous Local Reaction After Recombinant Hepatitis B Vaccine
M. Ollagnier, J. Perrot, E. Piriou-Fourel, W. Godar, F. Cambazard, G. Mounier
Pharmacovigilance Unit of the Second Chair of Pharmacology: Review and Analysis of 700 Notifications Received
G. A. Keller, M. F. Amato, M. Ponte, G. Di Girolamo
Monitoring Adverse Drug Reactions Using the Community Pharmacists: A Preliminary Study From Nepal
S. Palaian, M. Zham, P. Mishra
Web-Based Intensive Monitoring a New Method for Active Surveillance of Drugs
E. van Puijenbroek, L. Härmark, K. van Grootheest
Node Odontolgy in Pharmacovigilance’s University Network, Health Area, Universidad de la República
M. R. Romero Benvenuto, C. Seade Fournier
Follow-Up Suspects of Adverse Drug Reaction in the Hospital Nossa Senhora da ConceiÇão Identified by Drug Surveillance Method
L. Lindenmeyer, R. C. Mirandola, R. C. Bertogliox, F. Chiarani, G. Pizzoli, R. M. Levandovski, V. Hegele
“Off-Label Use” of Second Generation Antipsychotics in Psychiatric Inpatients — Data from the AMSP Study Group
A. Konstantinidisx, A. Kutzelnigg, R. Moser Grohmann, E. Jaquenoud Sirot, R. Engel, S. Kasper
Tú no Sabé Ingle… Contributing to Equality and Access to Independent Information in Argentina and Latin-American Spanish-Speaking Countries
R. Herrera, L. Alesso, C. Encrenaz
Safety Profile of Pimecrolimus Used in General Practice in England: A Prescription Event Monitoring study
Y. Buggy, L. Wilton, V. Marshall, S. Shakir
Safety Profile of Oxcarbazepine Used in General Practice in England: A Prescription Event Monitoring Study
Y. Buggy, D. Layton, V. Cornelius, L. Wilton, S. Shakir
Ethnopharmacovigilance: Special Considerations and Examples From Brazil
E. Rodrigues, J. Barnes
A Conceptual Review of Drugs In Environment: Case Studies in Present Scenario
V. Gupta, S. Z. Rahman
Intensive Pharmacovigilance in an Internal Medicine Unit of the University Hospital, Uruguay 2008
F. Cristiani, A. Danza, L. Lucas, M. Oyarzun, I. Aramendi, G. Giachetto
Pharmacovigilance Incorporation to Clinical Practice for Hospitalized Children Ongoing Antiepileptic Treatment
L. Lucas, H. Telechea, N. Speranza, S. Salazar, J. Ruiz, Y. Rodriguez, V. Braganca, K. Sal/mini, G. Giachetto, L. Nanni
Co-Proxamol Prescribing for Psychiatric Outpatients in Bahrain
K. A. Al Khaja, M. K. AI Haddad, A. R. Al-Offi, M. H. Abdulraheem, R. F. Sequeira
Safety Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study
R. Kasliwal, Y. Buggy, L. Wilton, S. Shakir
Patient Satisfaction with Chronic Pain Medication as an Indicator of Treatment Effectivity and safety
Md. G. Cunha, A. P. Macedo
Medication Error Reporting System at a Portuguese University Hospital: Results of the First six Months
A. F. Macedo, J. Ribeiro, O. Fonseca, C. Casteleiro
Using VigiSearch: Improving the Quality of Assessment
M. Bergman, V. Bologna, G. Rojas, I. Bignone
Perception of the Risk of Adverse Drug Reactions by Medical Students
G. Durrieu, C. Damase, C. Hurault, J. Montastruc
Serious Liver Injury Related to Antituberculous Drug
A. Zaiem, S. El Aïdli, S. Kastalli, F. Cherif, S. Srairi, M. H. Loueslafi, M. Lakhal, R. Daghfous, C. Belkahia
Anaphylactic Shock to Penicillin
A. Zaïem, S. El Aïdli, S. Kastalli, F. Cherif, M. H. Loueslati, R. Daghfous, C. Belkahia
Analysis of Anti-TNF Agents Suspected Adverse Drug Reactions (ADRs) Reported in Argentina in 2007
L. Alesso, R. Herrera, I. Bignone, V. Bologna
Peri-Infusion Rituximab Adverse Reactions in Mexican Patients with Non-Hodgkin Lymphoma
T. Arredondo-Garza, A. Majluf-Cruz, B. Vergara, G. Castañeda-Hernández
Selective serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
F. Oger, A. C. Buire, T. Trenque
Cholinesterase Inhibitors in Demented Patients: Impact of Treatment Non-Persistence on Institutionalization or Death
A. Pariente, Y. Moride, A. Dragomir, S. Perreault, A. Fourrier-Réglaf, N. Moore
Antipsychotic Use and Myocardial Infarction in Demented Patients Treated with cholinesterase Inhibitors
A. Pariente, Y. Moride, A. Dragomir, S. Perreault, A. Fourrier-Réglat, N. Moore
Case Series in Drug Safety Surveillance: Are they Useful as a Risk Management Tool?
A. Pariente, M. Pinet, N. Moore, Y. Moride
Antiepileptic Prescription and Monitoring Profile at children in a Pediatric Hospital
H. Telechea, N. Speranza, L. Lucas, S. Salazar, K. Salmini, J. Ruiz, Y. Rodriguez, V. Braganca, G. Giachetto, L. Nanni
Adverse Drugs Reactions in Hospitalized Children: A Public Health Problem
N. Speranza, L. Lucas, H. Telechea, A. Santurio, G. Giachetto, L. Nanni
Abatacept Adverse Events (AEs) in “Real Life”: Outpatient’s Data Collected Since Abatacept Licensing
L. Alesso, I. Strusberg, R. Herrera, A. Bertoli, M. Baravalle, Z. Betelu, P. Igarzábal, L. Morales, A. Strusberg
Inadvertent Rubella Vaccination of Pregnant Women during the Nationwide Rubella Vaccination Campaign in Buenos Aires, Argentina
A. S. Mistchenko, G. A. Keller, M. E. Acevedo, O. A. Jacquez, G. Di Girolamo, R. A. Diez
Comparison of Assessment Scales for Anticholinergic Drug Burden and the Association with the Occurrence of Delirium
R. Stuffken, M. Terlingen, E. Heerdink, C. Kalisvaart, M. Kerskes, R. van Marum, C. Van Rees, T. Egberts
Usefulness of MDBS in Identification and Analysis of Adverse Drug Reactions
S. Hernández, S. Pato, A. Albarracín, P. Bravo
ADR Frequency and Signal Informations Related with Sildenafil in South Korea
J. H. Ha, J. Y. Kim, M. S. Hwang, E. K. Yoon, D. D. Jang, T. M. Yoo
Ursodeoxycholic Acid Exposure in the First Trimester of Pregnancy
A. Gouraud, C. Garayt, N. Bernard, M. N. Beyens, T. Vial, J. Descotes
Drug-Induced Thrombotic Microangiopathy: An Analysis of the French Pharmacovigilance Database
A. Gouraud, N. Bernard, C. Garayt, M. Biour, C. Sgro, C. Noblet, C. Guy, A. P. Jonville-Bera, T. Vial
Drugs Associated with Ineffectiveness as Adverse Drug Reaction
S. Borgsteede, E. Van Puijenbroek, A. Passier, K. Van Grootheest
Osteonecrosis of the Jaw with Bisphosphonates: French Pharmacovigilance Data
T. Trenque, A. C. Buire, E. Herlem, M. L. Germain
Adverse Effects Related to Not Labelled Methylphenidate Indications in the French Pharmacovigilance Database
E. Herlem, M. L. Germain, T. Trenque
Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database
R. Leone, U. Moretti, A. Conforti, L. Magro, M. Moschini, M. Tuccori, P. Cutroneo, D. Motola, G. P. Velo
Medication Errors Detected By Retrospective Analysis in Pediatric Hospitalized Patients
A. Rosete, F. Tenorio, M. Zavaleta, R. Bolaños
Detection and Prevention of Adverse Drug Reactions in In-Patients of a Brazilian University Hospital
C. A. Takagi, M. C. S. Ricci, M. C. Sakai, G. G. França, S. C. Brassica, A. M. Yamaguchi, C. P. Rodrigues, E. Ribeiro
Filgrastim-Induced Sweet Syndrome with Acute Aortic Valve Insufficiency (Case Report)
M. L. Ponte, G. Di Girolamo, G. Keller
Pharmacovigilance, an Invaluable Tool to Gather New Information on Teratogenicity in Pregnancy
G. Lorena, P. Pieczanski, J. Rodriguez Moncalvo, F. Verra
Documentation Grading System: A Pilot Study from the Pharmacovigilance Department of ANMAT
M. Bergman, M. Parra, V. Bologna, R. Bolaños, I. Bignone
SOPs Standardization Impact: Application of Information and Communication Technologies (ICTs) as Educational Methods in Pharmacovigilance
L. Galeotti, P. Pieczanski, J. Rodriguez Moncalvo, F. Verra, C. Erba, S. Tornadore, G. Surra
Setup of a Model Pharmacovigilance Knowledge Process Outsourcing (KPO) Centre in India
A. Kakade, P. Biswas
Exposure to Drugs Contained in Semen During Conception and Pregnancy: A Potential Risk for Teratogenicity?
P. Pieczanski, L. Galeotti, J. Rodriguez Moncalvo, F. Verra
Comparison of Patient Information Leaflet (PIL) of Cardiac Drugs Marketed by Indian Companies with the original SmPC
M. Pawar, P. Chakraborty, P. Biswas
Adverse Events Supposedly Attributable to vaccination of Yellow Fever
S. Bentancourt, M. Valsecia, A. Perez, M. Bergman, I. Bignone
Patient Exposure Information: Data Sources and Use in Signal Detection and Safety Profiling
P. Chakraborty, V. Pannala, P. Biswas
Monitoring of Hematological Safety of Leponex® (Clozapine): Results of 14 Years
M. Fuentes-Vargas, A. Barrera-Islas, I. Bolaños-Pacheco, F. Fon-Mendez
Creation of an Electronic Database for the Reporting of Adverse Events from a Drug Adherence Program
A. Barrera-Islas, M. Fuentes-Vargas, F. Fon-Mendez
The Effect Lipid Lowering Drugs Statins on Increasing Risk of Albuminuria and Reduce of Renal Function: A Cohort Study
J. Thobari, R. Gansevoort, P. De Jong, L. De Jong-van Den Berg
Side Effects of Local Anaesthetic Drugs
I. Salouage, S. El Aidli, S. Kastalli, A. Zaiem, S. Srairi, M. H. Loueslati, R. Daghfous, C. Belkahia
Anaphylactic Shock with Coronary Stenting Thrombosis Induced By Amoxicillin-Clavulanic Acid
R. Charfi, S. El Aïdli, A. Zaïem, S. Kastalli, M. Lakhal, R. Daghfous, C. Belkahia
Descriptive Study of Teratovigilance Notifications
S. El Aidli, S. Kastalli, I. Salouage, A. Zaiem, W. Jebali, S. Srairi, M. Lakhal, R. Daghfous, C. Belkahia
Recurrent Fixed Drug Eruption due to Fluconazole
F. Cherif, A. Zaïem, S. Kastalli, R. Daghfous, C. Belkahia, S. El Aïdli
Severe Phenytoin Intoxication with Plasmatic Monitoring
R. Charfi, I. Salouage, A. Klouz, S. Trabelsi, I. Hamza, M. Lakhal, C. Belkahia
Serious Cutaneous Reactions to Carbamazepine
F. Cherif, S. El Aïdli, S. Kastalli, A. Zaïem, S. Sraïri, I. Salouage, M. Lakhal, R. Daghfous, C. Belkahia
Visual Disturbances Carbamazepine-Induced
F. Cherif, S. Kastalli, A. Zaïem, S. Sraïri, R. Daghfous, C. Belkahia, S. El Aïdli
Acyclovir Induced Sudden Coma: A Case Report
F. Cherif, S. El Aïdli, S. Kastalli, A. Zaïem, M. Lakhal, R. Daghfous, C. Belkahia
Peripheral Neuropathy during Infliximab Therapy for Rheumatoid Arthritis
F. Cherif, S. El Aïdli, S. Kastalli, A. Zaïem, M. Lakhal, R. Daghfous, C. Belkahia
Recurrent Fixed Drug Eruption due to Loratadine
S. Kastalli, S. El Aïdli, A. Zaïem, F. Cherif, R. Daghfous, C. Belkahia
Necrosis of the Eyelids after Local Anesthesia
S. Kastalli, S. El Aïdli, A. Zaïem, F. Cherif, R. Daghfous, C. Belkahia
Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina
C. Santucci, R. Papale, A. Perez, B. Cardoso, I. Bignone
Off-Label Use in Expectation-Based Medicine: The Point of View of a Health Insurance Institution (Provincial Administration of Health Insurance, AProSS)
L. Alesso, R. Herrera, A. Almada, I. Bencibenga, R. Rodriguez
Only Few Serious Adverse Drug Reactions Are Due to Drugs of Beers’ List of Inappropriate Medications for the Elderly
M. Rottenkolber, Y. Platel, S. Schmiedl, G. Haase, J. Hasford, P. A. Thuermann
Illegitimate High Price Medicines in Argentina in 2008
L. Alesso, R. Rodriguez, R. Herrera
Lack of Efficacy of Anesthetics in Public Hospitals of Cordoba, Argentina
K. Gatica, S. Lizzio, M. Longhi, M. Moressi, F. Deramo, J. Marioli, A. Vazquez, M. Rencoret, H. Macaño, E. Quinzio, V. Dabbene
Admissions by Bleeding or High INR Caused by Drugs in a Private Non-Profit Hospital, Montevideo, Uruguay
L. Olmos, G. Giachetto, V. Olmos, M. Daners, D. Szerman, J. Gesto
Retrospective Analysis of Pharmacy Dispensing Errors: Twelve Years Experience in a UK Hospital
A. R. Cox, S. Phull, V. Price, C. Anton, B. Hebron, N. J. Langford, R. E. Ferner
Development of Guideline and Macro Flow for Brazilian System of Pharmacovigilance: Basis for Decentralization
M. O. Bittencourt, M. F. Dias, P. M. Figueiredo, F. C. S. Cruz
Risk of Myocardial Infarction (MI) and Non Aspirin Non Steroidal Anti-Inflammatory Drugs (NANSAIDs): Analysis of a Depletion of Susceptibles Effect in the Risk of MI with Diclofenac: A Field Case-Control Study with the PGRx System
L. Bensouda-Grimaldi, M. Rossignol, F. Leclercq, N. Danchin, E. Autret-Leca, L. Abenhaim
Assessment of Medication Error Reports Sent to Brazilian Medicine Monitoring Centre (CNMM)
M. O. Bittencourt, S. C. C. Luiz, L. A. M. Silva, A. S. Santos, C. S. Teixeira, N. R. Souza, M. F. Dias
Pharmaceutical Care Practice: A Useful Tool in Pharmacovigilance
V. Pino Salomón, Y. Medina Berroteran
Protocol Writing: Requirements for Academic Sponsors in Terms of Safety
D. Bertram, A. Chiffoleau, C. Noblet, T. Trenque, E. Devilliers
Inventing a Drug Safety Program for Psychiatric Inpatients: AMSP (Arzneimittelsicherheit in der Psychiatrie)
A. Konstantinidis, R. Grohmann, E. Jaquenoud Sirot, P. Stephan, R. Engel, S. Kasper
“Off-Label Use” of Second Generation Antipsychotics in an Austrian Inpatient Population — Data from the Austrian AMSP
A. Konstantinidis, U. Moser, A. Kutzelnigg, R. Grohmann, R. Engel, S. Kasper
Strategies Impact to Increase the Reporting of Pharmacovigilance in a Brazilian University Hospital
H. C. Capucho, L. V. Reis, S. M. Siqueira, L. R. L. Pereira
Adverse Reactions to Drugs: Profile of University Hospital’s Notifications of the Brazilian Network of Sentinel Hospitals
H. C. Capucho, Nd. O. Costa
Incidence and Risk Factors for Agranulocytosis in Argentina: Results of a Substudy
D. Goldenberg, C. Marin, N. Hamerschlak, A. Biasi Cavalcanti, R. Plager, G. Drelichman, H. Ferro, M. P. Amoroso Copello, D. Fantl, M. P. Cárdenas, L. Palmer, G. Schwalb, F. Bezares, A. Goldenberg
Allergy-Immune Profile of High Risk Patients for Low Osmolality Contrast Media (LOCM) Adverse Drug Reactions (ADRs): A Basis for Prevention
G. Dozo, M. T. Serra, E. Menso, R. Herrera, L. Alesso
Diagnosis Tests for Diagnosing Allergic Contact Dermatitis in the Prevention of Adverse Reactions to Topic Medicines
M. T. Serra Criscuolo, G. Dozo, R. Herrera, L. Alesso
10 Years of Experiences with Consumer Reporting to KILEN — A Swedish Consumer Organisation
L. Westin, J. Albinson
Consumers and Health Care Professionals Differences in Reporting Trend: A Register-Based Study of Danish Adverse Drug Reactions Reports (2004–2006)
L. Aagaard, L. H. Nielsen, E. H. Hansen
Evaluation and Comparison of Two Methods of Causality Assessment in an Italian Spontaneous Reporting Database
G. Velo, M. Donati, L. Magro, R. Leone, A. Conforti, U. Moretti
The Adverse Medicine Events (AME) Line: Australian Experience with Consumer Pharmacovigilance
G. Moses, T. McGuire, J. McEwen